Hyperlipidemias Clinical Trial
Official title:
The Impact of a Fruit and Vegetable Provision Program on Cardiovascular Health
Verified date | April 2022 |
Source | Oregon Health and Science University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Participants in the intervention group of this study will receive weekly home deliveries of fruit & vegetables for 3 months. The primary objective of this study is to determine if increased access to fruits and vegetables leads to sustained dietary changes, measured through changes in the Healthy Eating Index (HEI). Secondary objectives are to determine whether increased fruit and vegetable access (increased HEI) ultimately leads to improved cardiovascular (CV) health indicators (e.g., body mass index, waist circumference, blood pressure, and levels of blood lipids and hemoglobin A1c).
Status | Completed |
Enrollment | 20 |
Est. completion date | December 15, 2020 |
Est. primary completion date | December 15, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years and older |
Eligibility | Inclusion Criteria: - Age 19 years and older - Established patient at OHSU Center for Preventive Cardiology - Not requiring changes to medication regimen for the 6-month study duration - Must be eligible to register with produce delivery company (reside in Portland-metro area; have access to a computer with internet service; able to read English) Exclusion Criteria: - Triglycerides > 500 mg/dL - Heavy alcohol use (> 3 drinks/day) - Uncontrolled hypertension (BP > 140/90) - LDL-C > 160 mg/dL - Uncontrolled diabetes mellitus (HbA1c > 8%) - Failure to provide informed consent - Current pregnancy - Healthy Eating Index (HEI) score of = 80 |
Country | Name | City | State |
---|---|---|---|
United States | Oregon Health & Science University | Portland | Oregon |
Lead Sponsor | Collaborator |
---|---|
Oregon Health and Science University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Intake of fruits and vegetables measured by changes in Healthy Eating Index (HEI) | The HEI uses a scoring system to evaluate a set of foods. The scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations from the Dietary Guidelines for Americans. | 6 months | |
Secondary | Changes in weight measured by body mass index | weight and height will be combined to report BMI in kg/m^2 | 6 months | |
Secondary | Changes in waist circumference | Waist circumference will be measured in inches using a tape measure; desirable: < 40 inches (men), < 35 inches (women) | 6 months | |
Secondary | Changes in total cholesterol | measured via blood draw, desirable < 200 mg/dL | 6 months | |
Secondary | Changes in HDL-cholesterol | measured via blood draw, desirable > 40 mg/dL | 6 months | |
Secondary | Changes in LDL-cholesterol | measured via blood draw, desirable < 100 mg/dL | 6 months | |
Secondary | Changes in triglycerides | measured via blood draw, desirable < 150 mg/dL | 6 months | |
Secondary | Changes in blood pressure | Measured by medical assistant in clinic, desirable < 120/80 mmHg | 6 months | |
Secondary | Changes in blood glucose | measured via blood draw, desirable range is 60-99 mg/dL | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03793985 -
Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337
|
Phase 1 | |
Recruiting |
NCT03947866 -
Ezetimibe-Rosuvastatin Evaluation Study
|
||
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Completed |
NCT04516291 -
A Dose-Ranging Study With Vupanorsen (TRANSLATE-TIMI 70)
|
Phase 2 | |
Completed |
NCT04701775 -
Effect of Different Probiotic Strains in Hypercholesterolemic Patients
|
N/A | |
Completed |
NCT03632668 -
Evaluating the Pharmacokinetic Interaction Between AD-2071 and AD-2072
|
Phase 1 | |
Completed |
NCT03534661 -
L-NMMA on GLP-2 Mediated Intestinal Lipoprotein Release
|
Phase 2/Phase 3 | |
Completed |
NCT03422666 -
Plasma Lipoprotein Response to Glucagon-like Peptide-2
|
Phase 2/Phase 3 | |
Completed |
NCT00536796 -
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
|
N/A | |
Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
Recruiting |
NCT04560296 -
Community-based E-Health Program for Older Adults Living With Chronic Diseases
|
N/A | |
Terminated |
NCT04073134 -
The CHORAL Flow Study
|
Phase 4 | |
Recruiting |
NCT05103254 -
Bempedoic Acid Pregnancy Surveillance Program
|
||
Not yet recruiting |
NCT05015348 -
Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients With Hyperlipidemia
|
N/A | |
Active, not recruiting |
NCT05082350 -
Nutritional Intervention With Black Garlic
|
N/A | |
Not yet recruiting |
NCT04398771 -
To Evaluate Safety and Effectiveness of RovatitanTab.
|
||
Not yet recruiting |
NCT04064281 -
The Healthy Cantonese Diet on Cardiometabolic Syndrome
|
N/A | |
Recruiting |
NCT06257641 -
Impact of the Mediterranean Diet on Patients With Psoriasis
|
N/A | |
Completed |
NCT03690778 -
The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.
|
Phase 1 | |
Completed |
NCT04354987 -
Compare the Pharmacokinetics and Safety of CKD-391
|
Phase 1 |